Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    15728811 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Discovery Stage Clinical Study About Oncology Drugs and Single Nucleotide Polymorphisms
Conditions: Stage, Prostate Cancer;   Surgery
Interventions: Drug: ABIRATERONE - Group 1;   Drug: ABIRATERONE - Group 2
2 Active, not recruiting BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
Condition: Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Bevacizumab
3 Completed
Has Results
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Conditions: Skin Rash;   Lung Cancer
Intervention: Drug: Tetracycline
4 Active, not recruiting Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   EGFR;   HER-2
Intervention: Drug: BIBW 2992
5 Withdrawn A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Intervention: Drug: BIBW 2992 (Afatinib)

Study has passed its completion date and status has not been verified in more than two years.